APO Research
Talk to an analyst

APO RESEARCH · REPORT

Gene Therapy on Neurological Diseases

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Gene Therapy on Neurological Diseases Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

2 January 2026173 pages

Choose your research edition.

Industry ResearchGene Therapy on Neurological Diseases Industry Research Report 2026103 pages · $2,950 USDIndustry Growth & TrendsGlobal Gene Therapy on Neurological Diseases Industry Growth and Trends Forecast to 203262 pages · $3,450 USDMarket StructureGlobal Gene Therapy on Neurological Diseases Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032173 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Gene Therapy on Neurological Diseases Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Gene Therapy on Neurological Diseases Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Gene Therapy on Neurological Diseases market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Gene Therapy on Neurological Diseases is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Gene Therapy on Neurological Diseases is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Gene Therapy on Neurological Diseases is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Gene Therapy on Neurological Diseases is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Gene Therapy on Neurological Diseases include Novartis, Biogen and Sarepta Therapeutics, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Gene Therapy on Neurological Diseases market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Gene Therapy on Neurological Diseases and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Gene Therapy on Neurological Diseases revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Gene Therapy on Neurological Diseases market size, projected growth trends, production technologies, key applications, and end-use industries.

Gene Therapy on Neurological Diseases Segment by Company

Novartis

Biogen

Sarepta Therapeutics

Gene Therapy on Neurological Diseases Segment by Type

Viral Gene Therapy

Non-viral Gene Therapy

Gene Therapy on Neurological Diseases Segment by Application

Hospital

Clinic

Other

Gene Therapy on Neurological Diseases Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gene Therapy on Neurological Diseases market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Gene Therapy on Neurological Diseases and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gene Therapy on Neurological Diseases.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Gene Therapy on Neurological Diseases in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Gene Therapy on Neurological Diseases industry.

Chapter 3: Detailed analysis of Gene Therapy on Neurological Diseases companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Gene Therapy on Neurological Diseasesrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Gene Therapy on Neurological Diseases Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Viral Gene Therapy Table 3. Key Players of Non-viral Gene Therapy Table 4. Global Gene Therapy on Neurological Diseases Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Hospital Table 6. Key Players of Clinic Table 7. Key Players of Other Table 8. Global Gene Therapy on Neurological Diseases Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 9. Global Gene Therapy on Neurological Diseases Market Size by Region (2021-2026) & (US$ Million) Table 10. Global Gene Therapy on Neurological Diseases Market Share by Region (2021-2026) Table 11. Global Gene Therapy on Neurological Diseases Market Size by Region (2027-2032) & (US$ Million) Table 12. Global Gene Therapy on Neurological Diseases Market Share by Region (2027-2032) Table 13. Gene Therapy on Neurological Diseases Industry Trends Table 14. Gene Therapy on Neurological Diseases Industry Drivers Table 15. Gene Therapy on Neurological Diseases Industry Opportunities and Challenges Table 16. Gene Therapy on Neurological Diseases Industry Restraints Table 17. Global Gene Therapy on Neurological Diseases Revenue by Company (US$ Million) & (2021-2026) Table 18. Global Gene Therapy on Neurological Diseases Revenue Market Share by Company (2021-2026) Table 19. Global Gene Therapy on Neurological Diseases Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 20. Global Gene Therapy on Neurological Diseases Key Company Head Office and Area Served Table 21. Global Gene Therapy on Neurological Diseases Company, Product Type & Application Table 22. Global Gene Therapy on Neurological Diseases Company Establishment Date Table 23. Global Company Market Concentration Ratio (CR5 and HHI) Table 24. Global Gene Therapy on Neurological Diseases by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 25. Global Gene Therapy on Neurological Diseases Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Gene Therapy on Neurological Diseases Market Size by Type (2021-2026) & (US$ Million) Table 27. Global Gene Therapy on Neurological Diseases Market Size by Type (2027-2032) & (US$ Million) Table 28. Global Gene Therapy on Neurological Diseases Revenue Market Share by Type (2021-2026) Table 29. Global Gene Therapy on Neurological Diseases Revenue Market Share by Type (2027-2032) Table 30. Global Gene Therapy on Neurological Diseases Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Gene Therapy on Neurological Diseases Market Size by Application (2021-2026) & (US$ Million) Table 32. Global Gene Therapy on Neurological Diseases Market Size by Application (2027-2032) & (US$ Million) Table 33. Global Gene Therapy on Neurological Diseases Revenue Market Share by Application (2021-2026) Table 34. Global Gene Therapy on Neurological Diseases Revenue Market Share by Application (2027-2032) Table 35. Novartis Company Information Table 36. Novartis Business Overview Table 37. Novartis Gene Therapy on Neurological Diseases Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Novartis Gene Therapy on Neurological Diseases Product Portfolio Table 39. Novartis Recent Development Table 40. Biogen Company Information Table 41. Biogen Business Overview Table 42. Biogen Gene Therapy on Neurological Diseases Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Biogen Gene Therapy on Neurological Diseases Product Portfolio Table 44. Biogen Recent Development Table 45. Sarepta Therapeutics Company Information Table 46. Sarepta Therapeutics Business Overview Table 47. Sarepta Therapeutics Gene Therapy on Neurological Diseases Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Sarepta Therapeutics Gene Therapy on Neurological Diseases Product Portfolio Table 49. Sarepta Therapeutics Recent Development Table 50. North America Gene Therapy on Neurological Diseases Market Size by Type (2021-2026) & (US$ Million) Table 51. North America Gene Therapy on Neurological Diseases Market Size by Type (2027-2032) & (US$ Million) Table 52. North America Gene Therapy on Neurological Diseases Market Size by Application (2021-2026) & (US$ Million) Table 53. North America Gene Therapy on Neurological Diseases Market Size by Application (2027-2032) & (US$ Million) Table 54. North America Gene Therapy on Neurological Diseases Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 55. North America Gene Therapy on Neurological Diseases Market Size by Country (2021-2026) Table 56. North America Gene Therapy on Neurological Diseases Market Size by Country (2027-2032) Table 57. Europe Gene Therapy on Neurological Diseases Market Size by Type (2021-2026) & (US$ Million) Table 58. Europe Gene Therapy on Neurological Diseases Market Size by Type (2027-2032) & (US$ Million) Table 59. Europe Gene Therapy on Neurological Diseases Market Size by Application (2021-2026) & (US$ Million) Table 60. Europe Gene Therapy on Neurological Diseases Market Size by Application (2027-2032) & (US$ Million) Table 61. Europe Gene Therapy on Neurological Diseases Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 62. Europe Gene Therapy on Neurological Diseases Market Size by Country (2021-2026) Table 63. Europe Gene Therapy on Neurological Diseases Market Size by Country (2027-2032) Table 64. China Gene Therapy on Neurological Diseases Market Size by Type (2021-2026) & (US$ Million) Table 65. China Gene Therapy on Neurological Diseases Market Size by Type (2027-2032) & (US$ Million) Table 66. China Gene Therapy on Neurological Diseases Market Size by Application (2021-2026) & (US$ Million) Table 67. China Gene Therapy on Neurological Diseases Market Size by Application (2027-2032) & (US$ Million) Table 68. Asia Gene Therapy on Neurological Diseases Market Size by Type (2021-2026) & (US$ Million) Table 69. Asia Gene Therapy on Neurological Diseases Market Size by Type (2027-2032) & (US$ Million) Table 70. Asia Gene Therapy on Neurological Diseases Market Size by Application (2021-2026) & (US$ Million) Table 71. Asia Gene Therapy on Neurological Diseases Market Size by Application (2027-2032) & (US$ Million) Table 72. Asia Gene Therapy on Neurological Diseases Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 73. Asia Gene Therapy on Neurological Diseases Market Size by Country (2021-2026) Table 74. Asia Gene Therapy on Neurological Diseases Market Size by Country (2027-2032) Table 75. South America, Middle East & Africa Gene Therapy on Neurological Diseases Market Size by Type (2021-2026) & (US$ Million) Table 76. South America, Middle East & Africa Gene Therapy on Neurological Diseases Market Size by Type (2027-2032) & (US$ Million) Table 77. South America, Middle East & Africa Gene Therapy on Neurological Diseases Market Size by Application (2021-2026) & (US$ Million) Table 78. South America, Middle East & Africa Gene Therapy on Neurological Diseases Market Size by Application (2027-2032) & (US$ Million) Table 79. South America, Middle East & Africa Gene Therapy on Neurological Diseases Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 80. South America, Middle East & Africa Gene Therapy on Neurological Diseases Market Size by Country (2021-2026) Table 81. South America, Middle East & Africa Gene Therapy on Neurological Diseases Market Size by Country (2027-2032) Table 82. Research Programs/Design for This Report Table 83. Authors List of This Report Table 84. Secondary Sources Table 85. Primary Sources List of Figures Figure 1. Gene Therapy on Neurological Diseases Product Image Figure 2. Global Gene Therapy on Neurological Diseases Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Gene Therapy on Neurological Diseases Market Share by Type: 2025 VS 2032 Figure 4. Viral Gene Therapy Image Figure 5. Non-viral Gene Therapy Image Figure 6. Global Gene Therapy on Neurological Diseases Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 7. Global Gene Therapy on Neurological Diseases Market Share by Application: 2025 VS 2032 Figure 8. Hospital Image Figure 9. Clinic Image Figure 10. Other Image Figure 11. Global Gene Therapy on Neurological Diseases Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Gene Therapy on Neurological Diseases Market Size (2021-2032) & (US$ Million) Figure 13. Global Gene Therapy on Neurological Diseases Market Share by Region: 2025 VS 2032 Figure 14. Years Considered Figure 15. Global Gene Therapy on Neurological Diseases Market Share by Players in 2025 Figure 16. Global Top 5 and 10 Gene Therapy on Neurological Diseases Players Market Share by Revenue in 2025 Figure 17. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Gene Therapy on Neurological Diseases Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Gene Therapy on Neurological Diseases Revenue Market Share by Type (2021-2032) Figure 20. Global Gene Therapy on Neurological Diseases Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Gene Therapy on Neurological Diseases Revenue Market Share by Application (2021-2032) Figure 22. North America Gene Therapy on Neurological Diseases Market Size (2021-2032) & (US$ Million) Figure 23. North America Gene Therapy on Neurological Diseases Market Share by Type (2021-2032) Figure 24. North America Gene Therapy on Neurological Diseases Market Share by Application (2021-2032) Figure 25. North America Gene Therapy on Neurological Diseases Market Share by Country (2021-2032) Figure 26. United States Gene Therapy on Neurological Diseases Market Size (2021-2032) & (US$ Million) Figure 27. Canada Gene Therapy on Neurological Diseases Market Size (2021-2032) & (US$ Million) Figure 28. Mexico Gene Therapy on Neurological Diseases Market Size (2021-2032) & (US$ Million) Figure 29. Europe Gene Therapy on Neurological Diseases Market Size (2021-2032) & (US$ Million) Figure 30. Europe Gene Therapy on Neurological Diseases Market Share by Type (2021-2032) Figure 31. Europe Gene Therapy on Neurological Diseases Market Share by Application (2021-2032) Figure 32. Europe Gene Therapy on Neurological Diseases Market Share by Country (2021-2032) Figure 33. Germany Gene Therapy on Neurological Diseases Market Size (2021-2032) & (US$ Million) Figure 34. France Gene Therapy on Neurological Diseases Market Size (2021-2032) & (US$ Million) Figure 35. U.K. Gene Therapy on Neurological Diseases Market Size (2021-2032) & (US$ Million) Figure 36. Italy Gene Therapy on Neurological Diseases Market Size (2021-2032) & (US$ Million) Figure 37. Russia Gene Therapy on Neurological Diseases Market Size (2021-2032) & (US$ Million) Figure 38. Nordic Countries Gene Therapy on Neurological Diseases Market Size (2021-2032) & (US$ Million) Figure 39. China Gene Therapy on Neurological Diseases Market Size (2021-2032) & (US$ Million) Figure 40. China Gene Therapy on Neurological Diseases Market Share by Type (2021-2032) Figure 41. China Gene Therapy on Neurological Diseases Market Share by Application (2021-2032) Figure 42. Asia Gene Therapy on Neurological Diseases Market Size (2021-2032) & (US$ Million) Figure 43. Asia Gene Therapy on Neurological Diseases Market Share by Type (2021-2032) Figure 44. Asia Gene Therapy on Neurological Diseases Market Share by Application (2021-2032) Figure 45. Asia Gene Therapy on Neurological Diseases Market Share by Country (2021-2032) Figure 46. Japan Gene Therapy on Neurological Diseases Market Size (2021-2032) & (US$ Million) Figure 47. South Korea Gene Therapy on Neurological Diseases Market Size (2021-2032) & (US$ Million) Figure 48. Taiwan Gene Therapy on Neurological Diseases Market Size (2021-2032) & (US$ Million) Figure 49. Southeast Asia Gene Therapy on Neurological Diseases Market Size (2021-2032) & (US$ Million) Figure 50. India Gene Therapy on Neurological Diseases Market Size (2021-2032) & (US$ Million) Figure 51. Australia Gene Therapy on Neurological Diseases Market Size (2021-2032) & (US$ Million) Figure 52. South America, Middle East & Africa Gene Therapy on Neurological Diseases Market Size (2021-2032) & (US$ Million) Figure 53. South America, Middle East & Africa Gene Therapy on Neurological Diseases Market Share by Type (2021-2032) Figure 54. South America, Middle East & Africa Gene Therapy on Neurological Diseases Market Share by Application (2021-2032) Figure 55. South America, Middle East & Africa Gene Therapy on Neurological Diseases Market Share by Country (2021-2032) Figure 56. Brazil Gene Therapy on Neurological Diseases Market Size (2021-2032) & (US$ Million) Figure 57. South Africa Gene Therapy on Neurological Diseases Market Size (2021-2032) & (US$ Million) Figure 58. Saudi Arabia Gene Therapy on Neurological Diseases Market Size (2021-2032) & (US$ Million) Figure 59. Turkey Gene Therapy on Neurological Diseases Market Size (2021-2032) & (US$ Million) Figure 60. Argentina Gene Therapy on Neurological Diseases Market Size (2021-2032) & (US$ Million) Figure 61. UAE Gene Therapy on Neurological Diseases Market Size (2021-2032) & (US$ Million) Figure 62. Egypt Gene Therapy on Neurological Diseases Market Size (2021-2032) & (US$ Million) Figure 63. Chile Gene Therapy on Neurological Diseases Market Size (2021-2032) & (US$ Million) Figure 64. Research Process Figure 65. Key Executives Interviewed

Scope & coverage.

Types
  • Viral Gene Therapy
  • Non-viral Gene Therapy
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Novartis
  • Biogen
  • Sarepta Therapeutics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Gene Therapy on Neurological Diseases Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Viral Gene Therapy
  5. 1.2.3 Non-viral Gene Therapy
  6. 1.3 Market Analysis by Application
  7. 1.3.1 Global Gene Therapy on Neurological Diseases Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  8. 1.3.2 Hospital
  9. 1.3.3 Clinic
  10. 1.3.4 Other
  11. 1.4 Global Market Growth Prospects
  12. 1.5 Global Gene Therapy on Neurological Diseases Growth Trends by Region
  13. 1.5.1 Global Gene Therapy on Neurological Diseases Market Size by Region: 2021 VS 2025 VS 2032
  14. 1.5.2 Gene Therapy on Neurological Diseases Market Size by Region (2021-2026)
  15. 1.5.3 Gene Therapy on Neurological Diseases Market Size by Region (2027-2032)
  16. 1.6 Assumptions and Limitations
  17. 1.7 Study Goals and Objectives
  18. 1.8 Years Considered
2 Global Gene Therapy on Neurological Diseases Market Dynamics
  1. 2.1 Gene Therapy on Neurological Diseases Industry Trends
  2. 2.2 Gene Therapy on Neurological Diseases Industry Drivers
  3. 2.3 Gene Therapy on Neurological Diseases Industry Opportunities and Challenges
  4. 2.4 Gene Therapy on Neurological Diseases Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Gene Therapy on Neurological Diseases Revenue by Company (2021-2026)
  2. 3.2 Global Gene Therapy on Neurological Diseases Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Gene Therapy on Neurological Diseases Key Company Head office and Area Served
  4. 3.4 Global Gene Therapy on Neurological Diseases Company, Product Type & Application
  5. 3.5 Global Gene Therapy on Neurological Diseases Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Gene Therapy on Neurological Diseases Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Gene Therapy on Neurological Diseases Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Gene Therapy on Neurological Diseases Tier 1, Tier 2, and Tier 3
4 Gene Therapy on Neurological Diseases Market by Type
  1. 4.1 Global Gene Therapy on Neurological Diseases Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Gene Therapy on Neurological Diseases Market Size by Type (2021-2032)
  3. 4.3 Global Gene Therapy on Neurological Diseases Market Size Share by Type (2021-2032)
5 Gene Therapy on Neurological Diseases Market by Application
  1. 5.1 Global Gene Therapy on Neurological Diseases Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Gene Therapy on Neurological Diseases Market Size by Application (2021-2032)
  3. 5.3 Global Gene Therapy on Neurological Diseases Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Novartis
  2. 6.1.1 Novartis Company Information
  3. 6.1.2 Novartis Business Overview
  4. 6.1.3 Novartis Gene Therapy on Neurological Diseases Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Novartis Gene Therapy on Neurological Diseases Product Portfolio
  6. 6.1.5 Novartis Recent Developments
  7. 6.2 Biogen
  8. 6.2.1 Biogen Company Information
  9. 6.2.2 Biogen Business Overview
  10. 6.2.3 Biogen Gene Therapy on Neurological Diseases Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Biogen Gene Therapy on Neurological Diseases Product Portfolio
  12. 6.2.5 Biogen Recent Developments
  13. 6.3 Sarepta Therapeutics
  14. 6.3.1 Sarepta Therapeutics Company Information
  15. 6.3.2 Sarepta Therapeutics Business Overview
  16. 6.3.3 Sarepta Therapeutics Gene Therapy on Neurological Diseases Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Sarepta Therapeutics Gene Therapy on Neurological Diseases Product Portfolio
  18. 6.3.5 Sarepta Therapeutics Recent Developments
7 North America
  1. 7.1 North America Gene Therapy on Neurological Diseases Market Size (2021-2032)
  2. 7.2 North America Gene Therapy on Neurological Diseases Market Size by Type
  3. 7.2.1 North America Gene Therapy on Neurological Diseases Market Size by Type (2021-2026)
  4. 7.2.2 North America Gene Therapy on Neurological Diseases Market Size by Type (2027-2032)
  5. 7.2.3 North America Gene Therapy on Neurological Diseases Market Share by Type (2021-2032)
  6. 7.3 North America Gene Therapy on Neurological Diseases Market Size by Application
  7. 7.3.1 North America Gene Therapy on Neurological Diseases Market Size by Application (2021-2026)
  8. 7.3.2 North America Gene Therapy on Neurological Diseases Market Size by Application (2027-2032)
  9. 7.3.3 North America Gene Therapy on Neurological Diseases Market Share by Application (2021-2032)
  10. 7.4 North America Gene Therapy on Neurological Diseases Market Size by Country
  11. 7.4.1 North America Gene Therapy on Neurological Diseases Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Gene Therapy on Neurological Diseases Market Size by Country (2021-2026)
  13. 7.4.3 North America Gene Therapy on Neurological Diseases Market Size by Country (2027-2032)
  14. 7.4.4 North America Gene Therapy on Neurological Diseases Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Gene Therapy on Neurological Diseases Market Size (2021-2032)
  2. 8.2 Europe Gene Therapy on Neurological Diseases Market Size by Type
  3. 8.2.1 Europe Gene Therapy on Neurological Diseases Market Size by Type (2021-2026)
  4. 8.2.2 Europe Gene Therapy on Neurological Diseases Market Size by Type (2027-2032)
  5. 8.2.3 Europe Gene Therapy on Neurological Diseases Market Share by Type (2021-2032)
  6. 8.3 Europe Gene Therapy on Neurological Diseases Market Size by Application
  7. 8.3.1 Europe Gene Therapy on Neurological Diseases Market Size by Application (2021-2026)
  8. 8.3.2 Europe Gene Therapy on Neurological Diseases Market Size by Application (2027-2032)
  9. 8.3.3 Europe Gene Therapy on Neurological Diseases Market Share by Application (2021-2032)
  10. 8.4 Europe Gene Therapy on Neurological Diseases Market Size by Country
  11. 8.4.1 Europe Gene Therapy on Neurological Diseases Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Gene Therapy on Neurological Diseases Market Size by Country (2021-2026)
  13. 8.4.3 Europe Gene Therapy on Neurological Diseases Market Size by Country (2027-2032)
  14. 8.4.4 Europe Gene Therapy on Neurological Diseases Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Gene Therapy on Neurological Diseases Market Size (2021-2032)
  2. 9.2 China Gene Therapy on Neurological Diseases Market Size by Type
  3. 9.2.1 China Gene Therapy on Neurological Diseases Market Size by Type (2021-2026)
  4. 9.2.2 China Gene Therapy on Neurological Diseases Market Size by Type (2027-2032)
  5. 9.2.3 China Gene Therapy on Neurological Diseases Market Share by Type (2021-2032)
  6. 9.3 China Gene Therapy on Neurological Diseases Market Size by Application
  7. 9.3.1 China Gene Therapy on Neurological Diseases Market Size by Application (2021-2026)
  8. 9.3.2 China Gene Therapy on Neurological Diseases Market Size by Application (2027-2032)
  9. 9.3.3 China Gene Therapy on Neurological Diseases Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Gene Therapy on Neurological Diseases Market Size (2021-2032)
  2. 10.2 Asia Gene Therapy on Neurological Diseases Market Size by Type
  3. 10.2.1 Asia Gene Therapy on Neurological Diseases Market Size by Type (2021-2026)
  4. 10.2.2 Asia Gene Therapy on Neurological Diseases Market Size by Type (2027-2032)
  5. 10.2.3 Asia Gene Therapy on Neurological Diseases Market Share by Type (2021-2032)
  6. 10.3 Asia Gene Therapy on Neurological Diseases Market Size by Application
  7. 10.3.1 Asia Gene Therapy on Neurological Diseases Market Size by Application (2021-2026)
  8. 10.3.2 Asia Gene Therapy on Neurological Diseases Market Size by Application (2027-2032)
  9. 10.3.3 Asia Gene Therapy on Neurological Diseases Market Share by Application (2021-2032)
  10. 10.4 Asia Gene Therapy on Neurological Diseases Market Size by Country
  11. 10.4.1 Asia Gene Therapy on Neurological Diseases Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Gene Therapy on Neurological Diseases Market Size by Country (2021-2026)
  13. 10.4.3 Asia Gene Therapy on Neurological Diseases Market Size by Country (2027-2032)
  14. 10.4.4 Asia Gene Therapy on Neurological Diseases Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Gene Therapy on Neurological Diseases Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Gene Therapy on Neurological Diseases Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Gene Therapy on Neurological Diseases Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Gene Therapy on Neurological Diseases Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Gene Therapy on Neurological Diseases Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Gene Therapy on Neurological Diseases Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Gene Therapy on Neurological Diseases Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Gene Therapy on Neurological Diseases Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Gene Therapy on Neurological Diseases Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Gene Therapy on Neurological Diseases Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Gene Therapy on Neurological Diseases Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Gene Therapy on Neurological Diseases Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Gene Therapy on Neurological Diseases Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Gene Therapy on Neurological Diseases Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst